Literature DB >> 9755024

Treatment with either high or low frequency TENS reduces the secondary hyperalgesia observed after injection of kaolin and carrageenan into the knee joint.

K A Sluka1, K Bailey, J Bogush, R Olson, A Ricketts.   

Abstract

For years, physical therapists have been utilizing a variety of modalities, including transcutaneous electrical nerve stimulation (TENS), in an attempt to manage pain associated with inflammation. However, the data on clinical effectiveness is conflicting and the neurophysiological mechanism of action is not known. The purpose of this study was to investigate the effects of high and low frequency TENS on the secondary hyperalgesia that occurs after joint inflammation. Secondary hyperalgesia is thought to reflect changes in central neurons and is thus a measure of activity of central neurons. This study utilized the kaolin and carrageenan model of knee joint inflammation and measured the effects of TENS treatment on paw withdrawal latency to radiant heat (secondary hyperalgesia), spontaneous pain behaviors and joint circumference. Either high (100 Hz) or low (4 Hz) frequency TENS was applied to the knee joint for 20 min after the development of hyperalgesia. Both high and low frequency TENS resulted in a reversal of the hyperalgesia immediately following treatment. The effects of high frequency TENS lasted through at least 24 h while those of low frequency TENS lasted through 12 h. There was no effect of TENS on spontaneous pain behaviors or joint swelling when compared to controls. Thus, TENS appears to be more effective in reducing referred pain (or secondary hyperalgesia) without affecting guarding or splinting of the affected limb. Thus, clinically, the choice to use TENS may depend on patient symptoms; specifically TENS should be effective in reducing referred or radiating pain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9755024     DOI: 10.1016/S0304-3959(98)00090-6

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  23 in total

1.  Joint manipulation reduces hyperalgesia by activation of monoamine receptors but not opioid or GABA receptors in the spinal cord.

Authors:  D A Skyba; R Radhakrishnan; J J Rohlwing; A Wright; K A Sluka
Journal:  Pain       Date:  2003-11       Impact factor: 6.961

2.  Release of GABA and activation of GABA(A) in the spinal cord mediates the effects of TENS in rats.

Authors:  Y Maeda; T L Lisi; C G T Vance; K A Sluka
Journal:  Brain Res       Date:  2007-01-16       Impact factor: 3.252

Review 3.  Using TENS for pain control: the state of the evidence.

Authors:  Carol G T Vance; Dana L Dailey; Barbara A Rakel; Kathleen A Sluka
Journal:  Pain Manag       Date:  2014-05

4.  Tachykinins Processing is Significantly Impaired in PC1 and PC2 Mutant Mouse Spinal Cord S9 Fractions.

Authors:  Mouna Saidi; Soufiane Kamali; Alberto Orduna Ruiz; Francis Beaudry
Journal:  Neurochem Res       Date:  2015-09-15       Impact factor: 3.996

5.  Conventional and kilohertz-frequency spinal cord stimulation produces intensity- and frequency-dependent inhibition of mechanical hypersensitivity in a rat model of neuropathic pain.

Authors:  Ronen Shechter; Fei Yang; Qian Xu; Yong-Kwan Cheong; Shao-Qiu He; Andrei Sdrulla; Alene F Carteret; Paul W Wacnik; Xinzhong Dong; Richard A Meyer; Srinivasa N Raja; Yun Guan
Journal:  Anesthesiology       Date:  2013-08       Impact factor: 7.892

6.  Transcutaneous electrical nerve stimulation for the control of pain during rehabilitation after total knee arthroplasty: A randomized, blinded, placebo-controlled trial.

Authors:  Barbara A Rakel; M Bridget Zimmerman; Katharine Geasland; Jennie Embree; Charles R Clark; Nicolas O Noiseux; John J Callaghan; Keela Herr; Deirdre Walsh; Kathleen A Sluka
Journal:  Pain       Date:  2014-09-28       Impact factor: 6.961

7.  A new transient sham TENS device allows for investigator blinding while delivering a true placebo treatment.

Authors:  Barbara Rakel; Nicholas Cooper; Heather J Adams; Bryan R Messer; Laura A Frey Law; Douglas R Dannen; Carrie A Miller; Anya C Polehna; Rachelle C Ruggle; Carol G T Vance; Deirdre M Walsh; Kathleen A Sluka
Journal:  J Pain       Date:  2009-11-27       Impact factor: 5.820

8.  Transcutaneous electrical nerve stimulation at both high and low frequencies activates ventrolateral periaqueductal grey to decrease mechanical hyperalgesia in arthritic rats.

Authors:  J M DeSantana; L F S Da Silva; M A De Resende; K A Sluka
Journal:  Neuroscience       Date:  2009-07-02       Impact factor: 3.590

9.  Blockade of NMDA receptors prevents analgesic tolerance to repeated transcutaneous electrical nerve stimulation (TENS) in rats.

Authors:  Priyanka M Hingne; Kathleen A Sluka
Journal:  J Pain       Date:  2007-12-03       Impact factor: 5.820

Review 10.  Transcutaneous electrostimulation for osteoarthritis of the knee.

Authors:  Anne Ws Rutjes; Eveline Nüesch; Rebekka Sterchi; Leonid Kalichman; Erik Hendriks; Manathip Osiri; Lucie Brosseau; Stephan Reichenbach; Peter Jüni
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.